Analysed DAXOR CORP (DXR:NASDAQ) News Sources
Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress
10-03-2026
yahoo.com
Updated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026
10-03-2026
yahoo.com
Daxor Details Portable FDA-Cleared Blood Volume Analyzer, 'Razor-and-Blades' Kit Growth at iAccess Alpha
15-03-2026
marketbeat.com
Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions
17-03-2026
yahoo.com
Dynamic announces March 2026 cash distributions for Dynamic Active ETFs and ETF Series
19-03-2026
yahoo.com
Daxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026
26-03-2026
yahoo.com
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
08-04-2026
yahoo.com
Dynamic announces April 2026 cash distributions for Dynamic Active ETFs and ETF Series
20-04-2026
yahoo.com
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
28-04-2026
yahoo.com
What is the current price of DAXOR CORP (DXR:NASDAQ)?
The current price of DAXOR CORP (DXR:NASDAQ) is $10.
DAXOR CORP (DXR:NASDAQ) absolute price change since previous trading day?
The absolute price change of DAXOR CORP (DXR:NASDAQ) since the previous trading day is $-0.1.
DAXOR CORP (DXR:NASDAQ) percentage price change since previous trading day?
The percentage price change of DAXOR CORP (DXR:NASDAQ) since the previous trading day is -0.9901%.
What is the most recent average sentiment score for DAXOR CORP (DXR:NASDAQ)?
The most recent average sentiment score for DAXOR CORP (DXR:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for DAXOR CORP (DXR:NASDAQ)?
The most recent sentiment for DAXOR CORP (DXR:NASDAQ) is .
SEC-8K** Filing Available For DAXOR CORP (DXR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.